SCHEMBL29071722

SCHEMBL29071722

NC1=N[N]C(c2cccc(F)c2)=C1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ MAPT P10636 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ TAAR1 Q96RJ0 3/20 0.47
▸ ADORA2A P29274 3/20 0.40
▸ MAP4K4 O95819 3/20 0.40
▸ ESR2 Q92731 1/20 0.39
▸ ADORA1 P30542 2/20 0.38
▸ ADORA2B P29275 1/20 0.38
▸ IDO1 P14902 2/20 0.38
▸ NOTUM Q6P988 1/20 0.38
▸ DPP4 P27487 1/20 0.37
▸ FYN P06241 1/20 0.37
▸ CHRNB4 P30926 1/20 0.37
▸ CHRNA3 P32297 1/20 0.37
▸ NISCH Q9Y2I1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29071607 0.79 RAB9A (0.47) KDM4EMEN1MAPTKMT2AIDO1
SCHEMBL29071715 0.79 RAB9A (0.47) MEN1KMT2AMAP4K4ADORA1IDO1
SCHEMBL29071592 0.79 TDO2 (0.46) TAAR1ADORA2AMAP4K4ADORA1ADORA2B
SCHEMBL29071601 0.77 RAB9A (0.41) KDM4EADORA2AMAP4K4ADORA1
SCHEMBL29071713 0.75 TDO2 (0.50) KDM4EMAPTKMT2AADORA2AMAP4K4
SCHEMBL20150481 0.69 MAP4K4 (0.68) KDM4EMEN1MAPTKMT2ATAAR1
SCHEMBL198702 0.68 TAAR1 (0.68) KDM4EMEN1MAPTKMT2ATAAR1
SCHEMBL18748036 0.67 ADORA2A (0.57) KDM4EMEN1MAPTKMT2ATAAR1
SCHEMBL16605628 0.66 TAAR1 (0.65) KDM4EMEN1MAPTKMT2ATAAR1
SCHEMBL16605626 0.66 TAAR1 (0.65) KDM4EMEN1MAPTKMT2ATAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116535356-A 3-amino-5-phenyl-pyrazole derivative tubulin inhibitor and preparation and medical application thereof 中国药科大学 2023-08-04 — — CN disclosed
Send feedback